Diagnostic test for etiologic agents of community-acquired pneumonia

John G Bartlett1

  • 1Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Johns Hopkins Hospital, 600 North Wolfe Street, Baltimore, MD 21205-2191, USA. jb@jhmi.edu

Insights

Diagnostic testing for community-acquired pneumonia (CAP) is not typically recommended for outpatients, who often improve with empiric antibiotics. For hospitalized patients, specific tests like blood cultures and Legionella testing are advised, with new PCR tests on the horizon.

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Clinical Diagnostics

Background:

  • Community-acquired pneumonia (CAP) diagnosis often lacks a specific etiologic agent identification in outpatients.
  • Empiric antibiotic therapy is common for CAP outpatients, often proving effective and cost-efficient compared to diagnostic tests.

Purpose of the Study:

  • To review current recommendations and emerging diagnostic strategies for identifying the causative agents of community-acquired pneumonia.
  • To guide the appropriate use of diagnostic tests in both outpatient and inpatient settings for CAP.

Main Methods:

  • Review of current clinical guidelines and diagnostic testing recommendations for CAP.
  • Discussion of established and novel diagnostic modalities, including blood cultures, sputum analysis, urinary antigen assays, and PCR.

Main Results:

  • Diagnostic tests are generally not recommended for most CAP outpatients.
  • For hospitalized CAP patients, pre-treatment blood cultures and sputum Gram stain/culture are recommended.
  • Testing for Legionella spp. is appropriate for severely ill hospitalized patients.
  • Emerging tests like urinary antigen assays for Streptococcus pneumoniae and PCR for Legionella pneumophila show promise for selected cases.

Conclusions:

  • Current diagnostic approaches for CAP vary significantly between outpatient and inpatient settings.
  • While empiric treatment is standard for outpatients, specific microbiological investigations are crucial for hospitalized individuals.
  • Advancements in molecular diagnostics, such as PCR, are expected to enhance etiological diagnosis for challenging CAP cases in the near future.

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...